Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Presented for research literature review only Provost E et al
An initial consultation establishes injury history, inflammatory markers, and organ function before any protocol is designed
Our knowledge is both theoretical and practical, and its always growing
Most users report visible improvements starting around 8 to 12 weeks of consistent injectable use, with optimal results building over 12 or more weeks of continuous administration
However, these clinical trials were conducted in Croatia and published in the early 2000s
Key publications: 'Tripeptide in human serum which prolongs survival of normal liver cells' (1973), 'Growth-modulating plasma tripeptide may function by facilitating copper uptake into cells' (1980, Nature), 'The human tri-peptide GHK and tissue remodeling' (2008), 'GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration' (2015), 'Regenerative and Protective Actions of the GHK-Cu Peptide' (2018)
